Skip to main content

HRT FINANCIAL LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1475597 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$3,478,462
+$2,515,175 QoQ
Shares Held
26,404
+284.8% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $86,437,876 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
26,404 $3,478,462

All Filings in NBIX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,478,462 26,404
2025-09-30 $963,287 6,862
2025-03-31 $572,797 5,179
2024-09-30 $5,115,191 44,395
2024-03-31 $5,791,674 41,993
2023-12-31 $2,588,556 19,646
2023-09-30 $8,635,837 76,763
2022-09-30 $2,081,609 19,599
2022-06-30 $4,280,346 43,910
2022-03-31 $1,298,343 13,849
2021-12-31 $1,962,742 23,045
2021-09-30 $2,125,461 22,161
2021-06-30 $764,448 7,855
2020-12-31 $331,257 3,456